2nd Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$1,106,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S.1089 "Restoring Access to Medication Act of 2019" provision to repeal tax provisions to prevent HSA eligibility for OTC medicines.

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 1089 (116th)

Copyright/Patent/Trademark CPT

Issues related to Compulsory Licensing; issues related to drug patents; and issues related to S. 1416 "Affordable Prescription for Patients Act of 2019".

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
AMY L REDL —
ELIZABETH STOWER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1416 (116th)

Budget/Appropriations BUD

Biodefense appropriation issues related to Biomedical Advanced Research and Development Authority (BARDA)

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
AMY L REDL —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to the HHS Rebate rule; general issues related to drug pricing; issues related to cosmetic regulations; issues related to insulin pricing; issues related to seasonal influenza vaccination; issues related to Drug Importation;issues related to s.102 "Prescription Drug Price Relief Act of 2019"; issues related to International Reference pricing; issues related to OTC Monograph Reform; issues related to Arbitration; issues related to H.R. 2087 "Drug Price Transparency Act"; issues related to S.977 "Medicare Drug Price Negotiation Act"; issues related to S.1379 " Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019"; and issues related to H.R. 269 "Pandemic and All Hazards Preparedness and Advancing Innovation Act of 2019:.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
KATIE OPPENHEIM —
AMY L REDL —
ELIZABETH STOWER —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 102 (116th), H.R. 2087 (116th), S. 977 (116th), S. 1379 (116th), H.R. 269 (116th)

Torts TOR

Issues related to S.340 "CREATES Act of 2019"; and issues related to HR 3199 "Terminating the Extension of Rights Misappropriated Act of 2019"

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
KATIE OPPENHEIM —
AMY L REDL —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 340 (116th), H.R. 3199 (116th)

Medicare/Medicaid MMM

Issues related to S.99 "Medicare Drug Price Negotiation Act"; issues related to blended ASP authorized generics; issues related to Medicaid AMP CAP; and issues related to international price index.

Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
JUAN MACHADO —
AMY L REDL —
ELIZABETH STOWER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 99 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.